0001753926-24-001955 Sample Contracts
CHANNEL THERAPEUTICS CORPORATION INDEMNIFICATION AGREEMENTIndemnification Agreement • November 18th, 2024 • Channel Therapeutics Corp • Biological products, (no disgnostic substances) • Nevada
This INDEMNIFICATION AGREEMENT (this “Agreement”) is made as of November 18, 2024 (the “Effective Date”), by and between Channel Therapeutics Corporation, a Nevada corporation (the “Company”), and [●] (the “Indemnitee”).
Standard Contracts
Agreement and plan of MergerMerger Agreement • November 18th, 2024 • Channel Therapeutics Corp • Biological products, (no disgnostic substances) • Nevada
This Agreement and Plan of Merger (“Agreement”), is effective as of November 18, 2024, by and between Chromocell Therapeutics Corporation, a Delaware corporation (“Merging Corporation”), and Channel Therapeutics Corporation, a Nevada corporation and wholly-owned subsidiary of Merging Corporation (the “Surviving Corporation”), pursuant to Section 253 of the General Corporation Law of the State of Delaware (the “DGCL”) and Chapter 92A.190 of the Nevada Revised Statutes (the “NRS”). Surviving Corporation and Merging Corporation are sometimes referred to herein collectively as the “Constituent Entities”.
